Siegmund Karasch
Director/Board Member chez DEUTSCHE BIOTECH INNOVATIV AG
Profil
Siegmund Karasch is the founder of AdrenoMed AG.
He is currently a Member-Supervisory Board at Deutsche Biotech Innovativ AG since 2018.
Previously, he worked as Chief Executive & Operating Officer at InVivo BioTech Services GmbH.
He completed his undergraduate degree from Hochschule für Technik und Wirtschaft Berlin in 1993.
Postes actifs de Siegmund Karasch
Sociétés | Poste | Début |
---|---|---|
DEUTSCHE BIOTECH INNOVATIV AG | Director/Board Member | 05/07/2018 |
Anciens postes connus de Siegmund Karasch
Sociétés | Poste | Fin |
---|---|---|
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Founder | 01/01/2014 |
InVivo BioTech Services GmbH
InVivo BioTech Services GmbH Medical SpecialtiesHealth Technology InVivo BioTech Services GmbH engages in contract manufacturing organization dedicated to the development and production of monoclonal antibodies and expression of recombinant proteins. The company was founded by Andreas Bergmann in 1998 and is headquartered in Hennigsdorf, Germany. | Chief Executive Officer | - |
Formation de Siegmund Karasch
Hochschule für Technik und Wirtschaft Berlin | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
DEUTSCHE BIOTECH INNOVATIV AG | Finance |
Entreprise privées | 2 |
---|---|
InVivo BioTech Services GmbH
InVivo BioTech Services GmbH Medical SpecialtiesHealth Technology InVivo BioTech Services GmbH engages in contract manufacturing organization dedicated to the development and production of monoclonal antibodies and expression of recombinant proteins. The company was founded by Andreas Bergmann in 1998 and is headquartered in Hennigsdorf, Germany. | Health Technology |
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Health Technology |